Cargando…

Oncogenic Tyrosine Phosphatases: Novel Therapeutic Targets for Melanoma Treatment

SIMPLE SUMMARY: Targeting oncogenic protein tyrosine phosphatases (PTPs) with specific pharmacological approaches has been considered for a long time a hard challenge, earning these PTPs the reputation of “undruggable” enzymes. Nevertheless, PTPs have been recognized as main targets for several dise...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pardella, Elisa, Pranzini, Erica, Leo, Angela, Taddei, Maria Letizia, Paoli, Paolo, Raugei, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7599540/ https://www.ncbi.nlm.nih.gov/pubmed/33003469 http://dx.doi.org/10.3390/cancers12102799

Ejemplares similares

Metabolic Features of Tumor Dormancy: Possible Therapeutic Strategies
por: Pranzini, Erica, et al.
Publicado: (2022)

Claisened Hexafluoro Inhibits Metastatic Spreading of Amoeboid Melanoma Cells
por: Leo, Angela, et al.
Publicado: (2021)

Therapy-Induced Stromal Senescence Promoting Aggressiveness of Prostate and Ovarian Cancer
por: Pardella, Elisa, et al.
Publicado: (2022)

Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion
por: Chiarugi, Paola, et al.
Publicado: (2003)

Evidence of Insulin-Sensitizing and Mimetic Activity of the Sesquiterpene Quinone Avarone, a Protein Tyrosine Phosphatase 1B and Aldose Reductase Dual Targeting Agent from the Marine Sponge Dysidea avara
por: Casertano, Marcello, et al.
Publicado: (2023)

Targeting of tumor cells by custom antigen transfer: a novel approach for immunotherapy of cancer
por: Nesi, Ilaria, et al.
Publicado: (2023)

Mitochondrial Oxidative Stress due to Complex I Dysfunction Promotes Fibroblast Activation and Melanoma Cell Invasiveness
por: Taddei, Maria Letizia, et al.
Publicado: (2012)

Targeting LMW‐PTP to sensitize melanoma cancer cells toward chemo‐ and radiotherapy
por: Lori, Giulia, et al.
Publicado: (2018)

Discovery of novel furanylbenzamide inhibitors that target oncogenic tyrosine phosphatase SHP2 in leukemia cells
por: Raveendra-Panickar, Dhanya, et al.
Publicado: (2021)

Therapeutic Potential of Targeting the Oncogenic SHP2 Phosphatase
por: Zeng, Li-Fan, et al.
Publicado: (2014)

The miR-27a/FOXJ3 Axis Dysregulates Mitochondrial Homeostasis in Colorectal Cancer Cells
por: Barisciano, Giovannina, et al.
Publicado: (2021)

Therapeutic Targeting of Protein Tyrosine Phosphatases from Mycobacterium tuberculosis
por: Ruddraraju, Kasi Viswanatharaju, et al.
Publicado: (2020)

Targeting a Cryptic Allosteric Site for Selective Inhibition of the Oncogenic Protein Tyrosine Phosphatase Shp2
por: Chio, Cynthia M., et al.
Publicado: (2014)

Protein Tyrosine Phosphatases in Neuroblastoma: Emerging Roles as Biomarkers and Therapeutic Targets
por: Nunes-Xavier, Caroline E., et al.
Publicado: (2021)

SHP2 phosphatase as a novel therapeutic target for melanoma treatment
por: Zhang, Ruo-Yu, et al.
Publicado: (2016)

Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma
por: Jin, Shaowen, et al.
Publicado: (2014)

Transcriptomic Analysis of Colorectal Cancer Cells Treated with Oil Production Waste Products (OPWPs) Reveals Enrichment of Pathways of Mitochondrial Functionality
por: Leo, Manuela, et al.
Publicado: (2022)

Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs OXPHOS and prostate cancer metastatic spread
por: Giannoni, Elisa, et al.
Publicado: (2015)

Targeting Protein-Tyrosine Phosphatases in Breast Cancer
por: Aceto, Nicola, et al.
Publicado: (2012)

The proto-oncogene Mer tyrosine kinase is a novel therapeutic target in mantle cell lymphoma
por: Shi, Cunzhen, et al.
Publicado: (2018)

Novel Small-Molecule Inhibitor for the Oncogenic Tyrosine Phosphatase SHP2 with Anti-Breast Cancer Cell Effects
por: Hartman, Zachary, et al.
Publicado: (2020)

Protein tyrosine phosphatase receptor delta acts as a neuroblastoma tumor suppressor by destabilizing the aurora kinase a oncogene
por: Meehan, Maria, et al.
Publicado: (2012)

Protein Tyrosine Phosphatase Non-Receptor 11 (PTPN11/Shp2) as a Driver Oncogene and a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC)
por: Richards, Cathy E., et al.
Publicado: (2023)

Protein tyrosine phosphatases: new markers and targets in oncology?
por: Hardy, S., et al.
Publicado: (2008)

Oncogenic mechanism-based pharmaceutical validation of therapeutics targeting MET receptor tyrosine kinase
por: Yao, Hang-Ping, et al.
Publicado: (2021)

Targeting oncogenes in advanced melanoma
por: McArthur, GA
Publicado: (2012)

Protein tyrosine phosphatase 1B as a therapeutic target for Graves’ orbitopathy in an in vitro model
por: Byeon, Hyeong Ju, et al.
Publicado: (2020)

Protein Tyrosine Phosphatase Receptor Gamma as Potential Therapeutic Target for Chronic Myeloid Leukemia Patients
por: Ismail, Mohamed A., et al.
Publicado: (2022)

Pan-cancer analyses of classical protein tyrosine phosphatases and phosphatase-targeted therapy in cancer
por: Wang, Tao, et al.
Publicado: (2022)

Activated fibroblasts enhance cancer cell migration by microvesicles-mediated transfer of Galectin-1
por: Toti, Alessandra, et al.
Publicado: (2021)

Phosphatase, pseudo-phosphatase, or both? Understanding PRL oncogenicity
por: Gehring, Kalle, et al.
Publicado: (2020)

Natural α-Glucosidase and Protein Tyrosine Phosphatase 1B Inhibitors: A Source of Scaffold Molecules for Synthesis of New Multitarget Antidiabetic Drugs
por: Genovese, Massimo, et al.
Publicado: (2021)

LMW-PTP targeting potentiates the effects of drugs used in chronic lymphocytic leukemia therapy
por: Capitani, Nagaja, et al.
Publicado: (2019)

Targeting an oncogenic kinase/phosphatase signaling network for cancer therapy
por: Qi, Xiao-Mei, et al.
Publicado: (2018)

The metal face of protein tyrosine phosphatase 1B()
por: Bellomo, Elisa, et al.
Publicado: (2016)

Prediction and verification of novel peptide targets of protein tyrosine phosphatase 1B
por: Li, Xun, et al.
Publicado: (2016)

Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
por: Song, Zhendong, et al.
Publicado: (2021)

Protein tyrosine phosphatase non-receptor type 2 as the therapeutic target of atherosclerotic diseases: past, present and future
por: Tang, Xiao-Er, et al.
Publicado: (2023)

The Protein Tyrosine Phosphatase H1 PTPH1 Supports Proliferation of Keratinocytes and is a Target of the Human Papillomavirus Type 8 E6 Oncogene
por: Taute, Stefanie, et al.
Publicado: (2019)

Characterization of New Substrates Targeted By Yersinia Tyrosine Phosphatase YopH
por: de la Puerta, María Luisa, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_efd6oehdgq928ru6ab76jgbr1t